Polycythaemia has developed in 10 of 59 regularly reviewed patients with renal transplants surviving more than three months. The pathology of the raised haemoglobin level was heterogeneous. Three patients had a picture characterized by a normal red cell mass and reduced plasma volume. Seven patients had a raised red cell mass; in 3 ofthese this was associated with a period of abnormal liver function and fitted with the state of raised red cell mass in association with hepatic transaminitis.
Introduction
Polycythaemia is a poorly recognized complication of renal transplantation. It is important, however, as it causes thromboses that may be prevented by venesecting the patients regularly. I have therefore studied the incidence and aetiology ofpolycythaemia after renal transplantation. Polycythaemia was diagnosed if the haematocrit was greater than 0.50 in males or 0.48 in females. Because an increased haematocrit may occur either due to a rise in red cell mass or through a reduction in plasma volume, the red cell mass of the patient was also measured. Patients who had a red cell mass greater than 25% of the predicted level (based on sex, height and weight) were assigned the diagnosis of true polycythaemia. Patients with a reduced plasma volume were assigned the diagnosis of relative polycythaemia (also known as apparent polycythaemia or Gaisbock's syndrome).
Patients and methods
During the period of the study 110 renal transplants were performed at Charing Cross Hospital, and 75 Prizewinning essay and runners up, Section of Pathology, 4 February 1986 grafts (68.2%) survived more than 3 months (the minimum time considered to develop polycythaemia). Of these, complete follow up details were available on 59 patients transplanted with their native kidneys in situ (33 cadaver, 26 living related grafts). Subsequent analysis was performed in these, as the 'at-risk' group. All patients were anaemic prior to transplantation.
5"Cr red cell mass and "3'I-labelled human serum albumin plasma volume' measurements were performed on diagnosis ofpolycythaemia. Arterial blood gases performed in all patients excluded hypoxia as a cause of secondary polycythaemia. Hepatocellular dysfunction was defined as a serum alanine aminotransferase (ALT) level of > 35 IU/l, and was an isolated abnormality in the 6 patients in whom it was raised.
Erythropoietin assay
For serum erythropoietin assay, 20 ml blood samples were taken and the serum immediately separated and deep-frozen at -20°C. Analysis was by modified fetal mouse liver bioassay utilizing semi-automatic harvesting of 125I deoxyuridine-labelled erythroblasts2.
Estimations were performed prior to venesection.
Culture studies Bone marrow obtained from iliac crest aspiration was separated by density centrifugation over lymphoprep (Nyegaard Oslo SG 1.077) and incubated at 37°C for two hours in Iscove's medium (Gibco) enriched with 10% fetal calf serum (Flow Labs) to remove the adherent cells. The non-adherent cell fraction was placed at a concentration of1 x 105/ml in 0.385% agar (Difco) in Iscoves Medium enriched with 30% pooled human serum; erythropoietin (Hyclone) was added in varying concentration from 0 to 1.25 units/ml in a total of 2 ml of culture medium.
The cultures were prepared in duplicate and incubated in a humidified atmosphere of 5% CO2 in air at 370. They were examined for colonies of erythroid cells recognized by the red colour due to haemoglobin on days 5-7, day 12, and day 15. The mononuclear cell fraction of peripheral blood was separated as above and duplicated cultures prepared containing 5 x 105 cells/2 ml. Colonies were counted as before. Peripheral blood was examined from the 4 patients with a raised red cell mass and uncomplicated posttransplant course and 4 normal volunteers. Bone marrow aspirates were examined from 3 of these patients and 7 controls (6 bone marrow donors and one patient without evidence of primary haematological disease).
Results
Three patients had apparent polycythaemia and 7 patients had true polycythaemia. The period of time between transplant and the return of normal renal function in the patients with apparent polycythaemia was 44 days, which was delayed. These The second group of 7 patients had true polycythaemia. A slow return to normal renal function (50 days) occurred in 3 of these, all of whom had complications at the time of transplanteither acute tubular necrosis, graft rejection or renovascular damage; they also had raised erythropoietin levels and a period of abnormal liver function. The 4 remaining patients in this group had no complications and a brisk return (17 days) to normal renal function. In addition, they had normal erythropoietin levels and maintained normal liver function in the post-graft period. Culture ofbone marrow from these 4 patients did not exhibit spontaneous formation of erythroid bursts, a feature which, when present, indicates a myeloproliferative syndrome such as primary polycy-thaemia3'4. In addition, there were no clinical or laboratory features to suggest primary polycythaemia in these patients. Numbers of colony-forming units in peripheral blood were similar in transplant patients and the normal controls. The colonies from the bone marrow cultures, however, showed significant increase in number as compared to the normal controls on all days on which colonies were counted. Figure 1 shows the results with erythropoietin added at 1.25 units/ml.
Discussion
Polycythaemia has occurred in 17% of a closely monitored transplant population. Polycythaemia may be true or apparent. A rise in haematocrit may occur in association with abnormal liver function5' 6, perhaps due to an increased level of erythropoietin derived from the liver. In some patients the increase in red cell mass due to this stimulus to erythropoiesis alone may be insufficient to raise the peripheral haematocrit, but in those in whom there is also a reduction in plasma volume consequent upon diuretic therapy, relative polycythaemia may occur, such as in the patients in Group 1. The true polycythaemia of the Group 2 patients with raised erythropoietin levels may be due to the hepatic dys-function5 6 or to an increased level of erythropoietin from the damaged kidneys7. The last 4 patients in this group had no defined risk factors for developing polycythaemia. A major component in the aetiology of anaemia or renal disease may be a group of inhibitors of erythropoiesis which possibly act as direct antagonists of erythropoietin. It is likely that rapid normalization ofrenal function in the uncomplicated post-transplant course reduces the inhibitor levels. The bone marrow newly released from this inhibition may be hypersensitive to erythropoietin and this causes expansion of the erythron with subsequent rise in haemoglobin level. This high circulating haemoglobin concentration is then maintained in the presence of a normal concentration of erythropoietin.
From this work, three conclusions may be drawn: first, post-transplant polycythaemia is common; secondly, the patients may have true or apparent polycythaemia; and thirdly, a group of patients with true erythrocytosis may have an increased sensitivity to erythropoietin in the post-transplant period.
